Artiva Biotherapeutics

Get a job referral to Artiva Biotherapeutics

California, United States

501-1000 Employees

Automotive

Healthcare

Tech

Description

Artiva Biotherapeutics is a cutting-edge biotechnology company specializing in the development of innovative cell therapies for cancer treatment. Leveraging advanced technologies and research, Artiva Biotherapeutics is at the forefront of the rapidly evolving field of cellular immunotherapy. The company's commitment to revolutionizing cancer care and improving patient outcomes drives its mission to deliver groundbreaking therapies that harness the power of the immune system to combat cancer.

Jobs

View all jobs at Artiva Biotherapeutics
[object Object]

Artiva Biotherapeutics

PEOPLE & CULTURE GENERALIST

California Full-timeAutomotive Healthcare Tech
[object Object]

Artiva Biotherapeutics

Director, Regulatory Affairs, CMC

San Diego CA Full-timeAutomotive Healthcare Tech
[object Object]

Artiva Biotherapeutics

Executive Director, Regulatory Operations

San Diego CA Full-timeAutomotive Healthcare Tech
[object Object]

Artiva Biotherapeutics

Associate, GxP Calibration and Maintenance

San Diego CA Full-timeAutomotive Healthcare Tech
[object Object]

Artiva Biotherapeutics

Senior Good Clinical Practice (GCP) Auditor

San Diego CA Full-timeAutomotive Healthcare Tech
[object Object]

Artiva Biotherapeutics

Manager/Senior Manager, Risk Management

San Diego CA Full-timeAutomotive Healthcare Tech
[object Object]

Artiva Biotherapeutics

Culture and Talent Manager

San Diego CA Full-timeAutomotive Healthcare Tech
[object Object]

Artiva Biotherapeutics

Associate/ Quality Control/ Environmental Monitoring

New York NY Full-timeAutomotive Healthcare Tech

About

Careers Page

artivabio.com

Financials

Type

public

Annual Revenue

--

Market Cap

$95.0M+

Subscribe to Refer Me premium to get referred to your dream role at Artiva Biotherapeutics!

Your career is worth investing in.

Try premium.

Upgrade to Premium

Refer Me logo

Refer Me

Referrals

Get Referred

Subscription

© 2025 Crucible Fund LLC. All rights reserved.